Revolutionizing Drug Discovery with AI

With the application of generative AI, the company is now poised for a revolution in drug discovery that will not only speed up the development of cancer medications but also result in significant financial savings. According to Alex Aliper, co-founder and president of Insilico Medicine, "the entire [drug discovery] process is extremely inefficient, slow, and expensive so it takes over 10 years to develop a drug." Alex Aliper spoke exclusively with Arabian Business.

Subscribe Channeliam YouTube Channels here:

Stay connected with us on: